Dr. Ana-Maria ToteaResearch Group

From Molecular Design to Clinical Reality

Developing innovative drug delivery systems, advanced biomaterials, and translational technologies for skin, hair and broader pharmaceutical research.

Scroll
Nanomedicine
3D Bioprinting
Drug Delivery
Microfluidics
Liposomes
MRSA Therapeutics
Chemotherapy-Induced Alopecia
Melt Electrowriting
SLA Printing
Clay-Drug Nanocomposites
Oral Dosage Forms
Bone Regeneration Scaffolds
Biocompatible Resins
Translational Science
Nanomedicine
3D Bioprinting
Drug Delivery
Microfluidics
Liposomes
MRSA Therapeutics
Chemotherapy-Induced Alopecia
Melt Electrowriting
SLA Printing
Clay-Drug Nanocomposites
Oral Dosage Forms
Bone Regeneration Scaffolds
Biocompatible Resins
Translational Science
Latest Publications
Full Archive
2025

Role of methicillin-resistant Staphylococcus aureus in cutaneous infections

International Journal of Pharmaceutics

4 citations
2025

Formulation and characterisation of resveratrol-loaded nanostructured lipid carriers

Journal of Drug Delivery Science and Technology

2 citations
2020

A molecular understanding of magnesium aluminium silicate–drug nanocomposite complex interactions

European Journal of Pharmaceutics and Biopharmaceutics

12 citations
Opportunities
Funded PhDPosition Filled

Targeted Nanoparticle Delivery to Protect Hair Follicles During Chemotherapy

University of Greenwich · Faculty of Engineering and Science

Develop nanoparticle-based drug delivery systems (liposomes, NLCs, polymeric nanocarriers) designed to protect hair follicles from chemotherapy-induced alopecia. Work at the interface of nanomedicine, pharmaceutical sciences and skin biology.

NanomedicineDrug DeliveryPharmaceutical SciencesSkin Biology

Deadline

30 April 2026

Funding

Fully Funded (UK Students Only)

Postdoctoral PositionPosition Filled

Post Doctoral Research Assistant — Chemotherapy-Induced Alopecia

University of Greenwich · School of Science, Medway Campus

Develop a novel dual-loaded liposomal hydrogel system for targeted hair follicle delivery to revolutionise management of chemotherapy-induced alopecia. Work at the interface of nanomedicine, pharmaceutical sciences and oncology, in collaboration with industry.

NanomedicineDrug DeliveryLiposomesOncology Supportive CareSkin Biology

Deadline

20 May 2026

Funding

£32,080 – £37,694 per annum · Fixed-Term to Aug 2028

Expression of Interest

Can't find the right fit?

We're always keen to hear from curious, motivated people. If none of the advertised roles match your background, tell us a little about yourself and your research interests — we may be able to create an opportunity together.

Prefer email? Write directly to a.totea@greenwich.ac.uk

By submitting, you agree to be contacted regarding research opportunities.

Contact & Affiliations

Location

University of Greenwich
School of Science
Faculty of Engineering and Science
London, United Kingdom

Contact

a.totea@greenwich.ac.uk

ORCID: 0000-0003-0974-7648

Affiliations

University of GreenwichAsiga Ambassador

Member, Royal Society of Chemistry

MSCS, Society of Cosmetic Scientists

Disclaimer: The views expressed here are those of the authors and not of the University of Greenwich.

Trail
base44
Edit with Base44